Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
United Parcel Service
UPS
|
+$428M |
| 2 |
DexCom
DXCM
|
+$384M |
| 3 |
WIX.com
WIX
|
+$359M |
| 4 |
FTCH
Farfetch Limited Class A Ordinary Shares
FTCH
|
+$254M |
| 5 |
Caesars Entertainment
CZR
|
+$246M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.14B |
| 2 |
Microchip Technology
MCHP
|
+$535M |
| 3 |
Merck
MRK
|
+$512M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$444M |
| 5 |
Illumina
ILMN
|
+$413M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.59% |
| 2 | Healthcare | 18.35% |
| 3 | Consumer Discretionary | 11.3% |
| 4 | Financials | 10.45% |
| 5 | Communication Services | 9.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
PayPal
PYPL
$49.5B
| $432M | 0.18% |
1,482,886
-9,405
| -0.6% | -$2.48M |
|
127
Burlington
BURL
$22B
| $431M | 0.18% |
1,339,916
+29,216
| +2% | +$9.3M |
|
128
Corning
GLW
$126B
| $423M | 0.18% |
10,353,056
+233,967
| +2% | +$10.2M |
|
129
Fastenal
FAST
$54B
| $421M | 0.18% |
16,194,546
+1,266,432
| +8% | +$32.9M |
|
130
Stryker
SYK
$127B
| $419M | 0.18% |
1,614,819
+72,608
| +5% | +$18.6M |
|
131
Estee Lauder
EL
$29B
| $418M | 0.18% |
1,315,813
-28,550
| -2% | -$8.66M |
|
|
NATI
132
DELISTED
National Instruments Corp
NATI
| $418M | 0.18% |
9,883,952
+186,410
| +2% | +$7.85M |
|
133
HP
HPQ
$23.5B
| $415M | 0.18% |
13,751,897
+820,329
| +6% | +$26.2M |
|
134
Ascendis Pharma A/S
ASND
$16.7B
| $411M | 0.18% |
3,127,171
-40,141
| -1% | -$5.35M |
|
135
Citigroup
C
$222B
| $411M | 0.18% |
5,810,844
+833,367
| +17% | +$61.7M |
|
136
Teleflex
TFX
$5.85B
| $407M | 0.17% |
1,013,144
+15,923
| +2% | +$6.53M |
|
137
Motorola Solutions
MSI
$69.4B
| $405M | 0.17% |
1,867,665
-52,363
| -3% | -$10.5M |
|
138
Flex
FLEX
$43.4B
| $404M | 0.17% |
29,974,756
+145,602
| +0.5% | +$1.98M |
|
139
CVS Health
CVS
$137B
| $399M | 0.17% |
4,783,455
+31,362
| +0.7% | +$2.57M |
|
140
AstraZeneca
AZN
$263B
| $396M | 0.17% |
3,305,317
+1,347,669
| +69% | +$148M |
|
141
General Dynamics
GD
$105B
| $396M | 0.17% |
2,103,262
+56,355
| +3% | +$10.6M |
|
142
Analog Devices
ADI
$181B
| $394M | 0.17% |
2,286,703
+255,337
| +13% | +$40.9M |
|
143
Hilton Worldwide
HLT
$74B
| $393M | 0.17% |
3,254,852
+235,370
| +8% | +$29.4M |
|
144
Novartis
NVS
$295B
| $387M | 0.17% |
4,238,667
-342,698
| -7% | -$30.5M |
|
145
Aramark
ARMK
$15B
| $384M | 0.16% |
14,261,712
+763,084
| +6% | +$20.9M |
|
146
Waters Corp
WAT
$36.8B
| $382M | 0.16% |
1,106,273
-100,540
| -8% | -$31.8M |
|
147
ResMed
RMD
$28.3B
| $381M | 0.16% |
1,547,352
-179,449
| -10% | -$37.7M |
|
148
Monster Beverage
MNST
$91.4B
| $379M | 0.16% |
8,306,256
-1,083,874
| -12% | -$50.9M |
|
|
MMP
149
DELISTED
Magellan Midstream Partners, L.P.
MMP
| $376M | 0.16% |
7,696,186
+16,617
| +0.2% | +$805K |
|
150
RB Global
RBA
$20.8B
| $374M | 0.16% |
6,316,344
+26,214
| +0.4% | +$1.61M |
|
Similar funds
Janus Henderson Group's Q2 2021 Portfolio in Review
As of Q2 2021, Janus Henderson Group held 1,725 positions worth $234B, up 6.7% from $219B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Janus Henderson Group's Q2 2021 filing shows 172 new, 741 increased, 667 reduced and 123 closed positions. Its largest new stake was Centessa Pharmaceuticals: 5,680,933 shares worth $120M. The largest sale was Apple, an estimated $1.14B.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 31% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Janus Henderson Group's largest Q2 2021 buy was Centessa Pharmaceuticals: 5,680,933 shares worth $120M.
- Janus Henderson Group added most to United Parcel Service in Q2 2021, an estimated $428M increase.
- Janus Henderson Group's biggest Q2 2021 reduction was Apple, cutting an estimated $1.14B.
- Janus Henderson Group fully exited PRA Health Sciences, Inc. in Q2 2021, selling an estimated $368M.
- Janus Henderson Group's ten largest holdings make up 23% of its $234B portfolio in Q2 2021.
- Janus Henderson Group opened 172 new positions and closed 123 in Q2 2021.
- Janus Henderson Group's portfolio value rose 6.7% quarter-over-quarter to $234B.
Based on Janus Henderson Group's 13F filing for Q2 2021, filed 16 Aug 2021.